Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Fajgenbaum

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Cell Reports. Medicine|December 30, 2020
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare DisorderSheila K Pierson, Johnson S Khor, Jasira Ziglar, et al.
Blood|January 15, 2017
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Thomas S Uldrick, Adam Bagg, et al.
Blood|September 6, 2018
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman diseaseFrits van Rhee, Peter Voorhees, Angela Dispenzieri, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteriaLu Zhang, Yu-Jun Dong, Hong-Ling Peng, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 8, 2026
Characterization of the genotypic and phenotypic spectrum of TCF7L2-related neurodevelopmental disorder (TRND)Sally Nijim, Mimi Kim, Melissa Denish, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Cell Reports. Medicine|December 30, 2020
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare DisorderSheila K Pierson, Johnson S Khor, Jasira Ziglar, et al.
Blood|January 15, 2017
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Thomas S Uldrick, Adam Bagg, et al.
Blood|September 6, 2018
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman diseaseFrits van Rhee, Peter Voorhees, Angela Dispenzieri, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteriaLu Zhang, Yu-Jun Dong, Hong-Ling Peng, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 8, 2026
Characterization of the genotypic and phenotypic spectrum of TCF7L2-related neurodevelopmental disorder (TRND)Sally Nijim, Mimi Kim, Melissa Denish, et al.
Pageof 12